ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

OLMA Olema Pharmaceuticals Inc

11.32
0.12 (1.07%)
After Hours
Last Updated: 16:00:10
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Olema Pharmaceuticals Inc OLMA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.12 1.07% 11.32 16:00:10
Open Price Low Price High Price Close Price Prev Close
11.21 10.79 11.50 11.32 11.20
more quote information »

Recent News

Date Time Source Heading
3/11/202416:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
3/11/202416:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/11/202416:05EDGAR2Form 8-K - Current report
3/11/202416:03GLOBEOlema Oncology Reports Fourth Quarter and Full-Year 2023..
3/06/202407:03GLOBEOlema Oncology Announces Publication of Data Highlighting..
3/04/202417:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202416:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
2/29/202414:26EDGAR2Form 144 - Report of proposed sale of securities
2/14/202416:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202412:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202417:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2/12/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
2/06/202407:01GLOBEOlema Oncology to Participate in Upcoming Investor..
2/05/202417:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/05/202417:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/05/202417:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
2/01/202415:24EDGAR2Form 144 - Report of proposed sale of securities
1/31/202416:21EDGAR2Form S-3 - Registration statement under Securities Act of..
1/31/202414:58EDGAR2Form 144 - Report of proposed sale of securities
1/29/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202409:07EDGAR2Form 8-K - Current report
1/08/202408:18EDGAR2Form 8-K - Current report
1/08/202408:12GLOBEOlema Oncology Nominates OP-3136, an Orally Bioavailable..
1/05/202417:26EDGAR2Form 8-K - Current report
1/05/202417:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
1/02/202417:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/02/202416:01GLOBEOlema Oncology to Present at 42nd Annual J.P. Morgan..
12/29/202315:54EDGAR2Form 144 - Report of proposed sale of securities
12/18/202318:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202317:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/08/202316:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/07/202320:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/07/202320:30EDGAR2Form 3/A - Initial statement of beneficial ownership of..
12/06/202307:48EDGAR2Form 8-K - Current report
12/05/202317:15EDGAR2Form 8-K - Current report
12/05/202312:27GLOBEOlema Oncology Announces Palazestrant Demonstrates..
12/04/202316:29GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
12/01/202317:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/30/202310:20EDGAR2Form 144 - Report of proposed sale of securities
11/28/202317:10GLOBEOlema Oncology to Present New Palazestrant Clinical Data in..
11/22/202319:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202319:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202319:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202319:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202315:25EDGAR2Form 144 - Report of proposed sale of securities
11/22/202315:04EDGAR2Form 144 - Report of proposed sale of securities
11/22/202314:42EDGAR2Form 144 - Report of proposed sale of securities
11/22/202314:35EDGAR2Form 144 - Report of proposed sale of securities

Your Recent History

Delayed Upgrade Clock